SAB Biotherapeutics, Inc. - SABS

SEC FilingsOur SABS Tweets

About Gravity Analytica

Recent News

  • 05.09.2025 - SAB BIO Announces Q1 2025 Financial Results and Provides Company Updates
  • 03.31.2025 - SAB BIO Reports Full Year 2024 Operating and Financial Results
  • 03.03.2025 - Hua Wu, PhD
  • 03.03.2025 - Stan Stoyanov, MD, MBA
  • 03.03.2025 - Angie Parizek
  • 03.03.2025 - Thomas Luke, MD, MTMH, MA, BS
  • 03.03.2025 - Kaelan Hollon, JD
  • 03.03.2025 - Catherine DeRose
  • 03.03.2025 - Mark Conley, MBA
  • 03.03.2025 - Carlos Carrillo, Ph.D.

Recent Filings

  • 04.03.2025 - S-8 Securities to be offered to employees in employee benefit plans
  • 04.01.2025 - 4 Statement of changes in beneficial ownership of securities
  • 03.31.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
  • 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 02.05.2025 - 8-K Current report